The AKEPSI brand, founded in 2014 (United Kingdom), from 1722 sister brands and 17477 competing brands. AKEPSI is owned by GSK PLC, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is GB00BN7SWP63. AKEPSI is part of the Drug Manufacturers activity sector.

AKEPSI is a brand of GSK PLC (GS71) Share price

International deposit : 2014 Business sector Drug Manufacturers

Share price and profitability of the share GSK PLC (AKEPSI)

Buy GSK PLC share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 19.52

Portfolio valuation
GSK PLC (AKEPSI) over 5 years* EUR 17.05

Stock market history GSK PLC (AKEPSI)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
GSK PLC

Twinrix
Twinrix
Trizivir
Trizivir
Triumeq
Triumeq
Retrovir
Retrovir
Pediarix
Pediarix
Mepron
Mepron
See more brands of GSK PLC

Rival brands
AKEPSI

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS